Elsevier

Microbial Pathogenesis

Volume 92, March 2016, Pages 72-75
Microbial Pathogenesis

Correlation between clinical symptoms and peripheral immune response in HAM/TSP

https://doi.org/10.1016/j.micpath.2015.11.018Get rights and content

Highlights

  • HTLV-1 infects principally CD4+ T cells that are the main reservoirs of the virus in vivo.

  • HAM/TSP is a chronic inflammatory disease of the central nervous system.

  • An increased expression of IFN genes was observed in patients with HAM/TSP.

Abstract

HTLV-1 infects principally CD4+ T cells that are the main reservoirs of the virus in vivo, which play an important role in the immunological response. Most of the infected patients are asymptomatic. However, 2–3% of patients will develop HAM/TSP or Adult T lymphoma. HAM/TSP is a chronic inflammatory disease of the central nervous system, which is characterized by unremitting myelopathic symptoms. Studies have shown that cytokines levels alterations (IFN-γ and TNF-α) were associated with tissue injury in HAM/TSP. The aims of this study were to compare the gene expression of IFN-γ, IL-4 and IL-10 of asymptomatic and HAM/TSP HTLV-1 infected patients, and to correlate the gene expression with those of clinical symptoms. 28 subjects were included, 20 asymptomatic HTLV-1 and 8 with HAM/TSP. Spasticity was evaluated using the Modified Ashworth Scale and the degree of walking aid was classified on a progressive scale. The relative gene expression of IFN-γ, IL-4, and IL-10 was measured by Real-Time PCR. Results showed high gene expression of IFN-γ for all patients, but it was higher among HAM/TSP. A significant correlation was observed between IFN-γ gene expression and the degree of walking aid, and IFN-γ gene expression was higher among wheelchair users compared to non-wheelchair users. No association was found with IL-4 and IL-10. These findings indicate that HAM/TSP patients express higher amounts of IFN-γ than asymptomatic patients, and more importantly, the expression of this cytokine was strongly correlated with the need of walking aid.

Introduction

Human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus that infects 10 to 20 million people worldwide [1], [2], [3], [4], [5]. Most infected individuals remain asymptomatic. However, approximately 3–5% of infected subjects develop adult T-cell leukemia/lymphoma or HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a chronic inflammatory disease of the central nervous system (CNS) [2], [6], [7]. CD4+ T cells are the main reservoir of this virus, but other cells such as CD8+ T cells may also be infected [8], [9], [10], [11].

HTLV-1-infected CD4+ T cells and HTLV-specific CD8+ T cells play an important role in HAM/TSP pathogenesis [8], [12], [13]. These cells usually infiltrate the CNS [3], [14], and they are responsible for producing neurotoxic cytokines (TNF-α, IFN-γ, and IL1-β [14]. In addition, studies have shown that these neurotoxic cytokines in peripheral blood are important mediators of tissue injury in HAM/TSP [8], [15], [16], [17], [18]. Studies showed that, not just TH1 response is higher, but TH2 response is diminished presenting low levels of IL-4 [19], [20], [21]. Studies focused on the role of T regulatory cells in HTLV-1 infection presenting reduction in its function. Patients that developed HAM/TSP had decreased FOXP3 expression and production of the IL-10 and TGF-b, which are cytokines responsible for suppression of the immune response [11], [20], [21], [22], [23]. Pathological descriptions of HAM/TSP indicate involvement of the lower thoracic spinal cord, which is characterized by the loss of myelin and axons [18], [24], [25], [26], [27], [28]. Inflammation of the spinal cord, in turn, causes weakness and spasticity of the lower limbs, gait disturbances, paresthesia, bladder/bowel dysfunction, and erectile dysfunction in men [15], [24], [26], [28], [29], [30].

This study aimed to compare the gene expression of IFN-γ, IL-4 and IL-10 in peripheral blood between HAM/TSP and asymptomatic HTLV-1 infected patients. Also the gene expression of IFN-γ, IL-4 and IL-10 in peripheral blood was correlated with the clinical symptoms seen in HAM/TSP patients.

Section snippets

Materials and methods

Eight HAM/TSP and 20 asymptomatic HTLV-1 patients were studied. They were recruited from the outpatient clinic of the Tropical Medicine Institute, Pará Federal University, Brazil. For HTLV-1 detection, ELISA exam was performed and confirmed by PCR reaction. The diagnosis of HAM/TSP was based on WHO criteria [31]. Spasticity was evaluated using the Modified Ashworth Scale [32], and the degree of walking aid was classified on a progressive scale (Table 1).

Five mL of peripheral blood was collected

Results

The asymptomatic HTLV-1 group had 17 women and 3 men (Mean age of 49.2 years). Among the HAM/TSP group were 5 women and 3 men (Mean age of 50 years).

Only the left plantar flexors showed higher spasticity degree. The others muscles showed lower spasticity degree (Fig. 1). Seven patients with HAM/TSP required the use of walking aid (Table 1).

The gene expression showed higher expression of Th1 cytokine in all patients. In HAM/TSP patients, expression levels were higher for IFN-γ when compared to

Discussion

Several aspects of the pathogenesis of HAM/TSP remain to be elucidated. Studies suggest that the balance between inflammatory and regulatory cytokines play a major role in the development of this disease. An imbalance in the Th1/Th2 system in HAM/TSP patients, characterized by a higher expression of Th1 cytokines, may cause chronic inflammation of the spinal cord. This process, in turn, may result in neural damage which are responsible for the neurological symptoms [15], [24], [29], [30].

Conclusions

These results show that HTLV-1 infected patients have an IFN-γ overexpression, which is higher in HAM/TSP patients. This inflammatory response is correlated to development and progression of HAM/TSP, which is evidenced by the correlation of IFN-γ levels and use of walking aid. New studies are warranted to look into more specific mechanisms that could help to design novel medications to improved clinical outcome.

Ethical approval

The project has been given ethical approval from the Nucleus of Tropical Medicine Committee on Human Research (Protocol No. 038/2010) and informed written consent was obtained from each patient.

Funding

This study was supported by CNPQ and Immunophathology Laboratory – University of Pará- Brazil.

Competing interests

None declared.

References (41)

  • T. Watanabe

    Current status of HTLV-1 infection

    Int. J. Hematol.

    (2011)
  • L.C. Romanelli et al.

    Human T-cell lymphotropic virus type 1 (HTLV-1): when to suspect infection?

    Rev. Assoc. Med. Bras.

    (2010)
  • M. Saito

    Immunogenetics and the pathological mechanisms of human T-cell leukemia virus type 1- (HTLV-1-) associated myelopathy/tropical spastic paraparesis (HAM/TSP)

    Interdiscip. Perspect. Infect. Dis.

    (2010)
  • D.U. Gonçalves et al.

    HTLV-1-Associated Myelopathy/Tropical spastic paraparesis (HAM/TSP) inflammatory Network

    Inflamm. Allergy Drug. Targets

    (2008)
  • E. Majorovits et al.

    Human T-lymphotropic virus-1 visualized at the virological synapse by electron tomography

    PLoS One

    (2008)
  • Y. Satou et al.

    HTLV-1 and the host immune system: how the virus disrupts immune regulation, leading to HTLV-1 associated diseases

    J. Clin. Exp. Hematop

    (2010)
  • M.F. Grassi et al.

    Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP

    J. Med. Virol.

    (2011)
  • C. Journo et al.

    HTLV-1 and innate immunity

    Viruses

    (2011)
  • Y. Yamano et al.

    Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis

    Front. Microbiol.

    (2012)
  • I. Best et al.

    IFN-gamma production in response to Tax 161-223, and frequency of CD4+Foxp3+ and Lin HLA Rhigh CD123+ cells, discriminate HAM/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population

    Immunology

    (2009)
  • Cited by (12)

    View all citing articles on Scopus
    View full text